RDLH-$5.60-COVID PILL"...a small, Israeli/U.S. upstart, RedHill Biopharma Ltd. (NASDAQ:RDHL), has quietly raced to the front of the pack for a novel COVID pill with its two-pronged oral development program..."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.